Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-29

The Development of Immunotherapeutic Strategies to Treat Haematological and Neoplastic diseases on the Basis of Optimised Allogeneic Stem Cell Transplantation

Cel

Haematological disease, either malignant or otherwise, carries a significant burden of morbidity and mortality. Recent advances in mapping and sequencing of the human genome make possible an approach to the treatment of these diseases which exploits the genetic differences between individuals to produce targets through which the immune system can eliminate the diseased cells. In practice this process of immunotherapy involves an allogeneic haematopoietic stem cell transplant, with subsequent delivery of specific immune effector cells expanded from the donor. The AlloStem project brings together clinical and research groups from across the EU who individually is amongst the world leaders in the field of immunotherapy to coordinate and complement their efforts into a unified and directed program. We will develop new protocols for the treatment of patients with haematological disease and for the effective delivery of immunogenomics-based therapies. The end results of the project will be both an improvement in the health care for EU citizens and the development of new genome-based pharmaceuticals that can be exploited worldwide.

Dziedzina nauki

Słowa kluczowe

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

FP6-2002-LIFESCIHEALTH
Zobacz inne projekty w ramach tego zaproszenia

System finansowania

IP - Integrated Project

Koordynator

THE ANTHONY NOLAN TRUST
Wkład UE
Brak danych
Adres
The Royal Free Hospital, Pond Street, Hampstead
LONDON
Zjednoczone Królestwo

Zobacz na mapie
Linki
Koszt całkowity
Brak danych

Uczestnicy (28)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 4 Sierpnia 2008

Moja broszura

Permalink: https://cordis.europa.eu/project/id/503319/pl

European Union, 2024